Stearns Cough Syrup 100mg / 5ml Syrup
Clinical Summary
Quick overview from the medicine insert
Indication
Alleviation of cough associated with viscid/tenacious phlegm.
Dosage (summary)
Adults: 200-400 mg (10-20 ml) every 4 hours; max 2400 mg (120 ml) in 24 hours.
Special Populations
- Children under 2 years
Pregnancy & Breastfeeding
Safety in pregnancy and lactation not established; unknown if distributed in breast milk.
Key Drug Interactions
- Interferes with urine tests for 5-HIAA and VMA
Contraindications
- Hypersensitivity to ingredients
- Porphyria
Common side effects
- Nausea
- Vomiting
- Diarrhoea
- Dizziness
- Headache
Counselling Points
- Do not exceed recommended dosage
- Keep out of reach of children
Serious warnings
- Persistent cough may indicate serious condition
- Consult doctor if cough persists over one week
The Stearns Cough Syrup 100mg / 5ml Syrup professional information leaflet below is the property of Adcock Ingram and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
Clinical Particulars
Section 4 of the official insert — extracted exactly as issued, no alterations
4.1 Therapeutic indications
Alleviation of cough associated with viscid/tenacious phlegm.
4.2 Posology and method of administration
Adults and children 12 years and over: Oral dosage is 200 mg to 400 mg (10 ml to 20 ml) every 4 hours. Do not exceed 2 400 mg (120 ml) in 24 hours.
Children 6 to under 12 years: Oral dosage is 100 mg to 200 mg (5 ml to 10 ml) every 4 hours. Do not exceed 1 200 mg (60 ml) in 24 hours.
Children 2 to under 6 years: Oral dosage is 50 to 100 mg (2,5 ml to 5 ml) every 4 hours. Do not exceed 600 mg (30 ml) in 24 hours, or as directed by a doctor.
4.3 Contraindications
Hypersensitivity to any of the ingredients. Porphyria (see u2018WARNINGS AND SPECIAL PRECAUTIONSu2019).
4.4 Special warnings and precautions for use
A persistent cough may be a sign of a serious condition. If cough persists for more than one week, tends to recur or is accompanied by high fever, skin rash, sore throat or persistent headache, consult a doctor.
STEARNS should not be given to children under 2 years unless recommended by a doctor.
Porphyria: Safety has not been established.
4.5 Interactions with other medicines
Guaiphenesin interferes with urine tests for 5-hydroxyindoleacetic acid (5-HIAA) and vanillylmandelic acid (VMA).
4.6 Fertility, pregnancy and lactation
Pregnancy: The safety of this medicine in pregnancy and lactation has not been established.
Lactation: It is not known whether guaiphenesin is distributed into breast milk. However, problems in humans have not been documented.
4.8 Undesirable effects
Gastrointestinal disorders: Less frequent: nausea, vomiting, diarrhoea, stomach pain and gastrointestinal discomfort.
Nervous system disorders: Less frequent: dizziness and headache.
Skin and subcutaneous tissue disorders: Less frequent: skin rash and urticaria.
4.9 Overdose
Signs and symptoms of overdosage: Very large doses can cause gastrointestinal discomfort, nausea and vomiting.
Treatment of overdose: Treatment is symptomatic and supportive.